Childhood epilepsy is more than seizures. Learn to recognize symptoms, manage triggers, and support your child’s well-being.

Both add-on therapy and substitution monotherapy are equally effective as second-line treatments for women with idiopathic generalized epilepsy, new research suggests.

According to the latest research study, the global epilepsy treatment devices market was valued at approximately USD 526.8 Million in 2023 and is expected to reach a value of around USD 787.3 Million ...

FORT LAUDERDALE, Fla. (AP) — U.S. Attorney General Pam Bondi on Wednesday announced the seizure of roughly $510 million worth ...

Sustained efficacy and tolerability in a range of vulnerable patients: Long-term open label extension data of adjunctive XCOPRI for ≥4 years in adults show up to 16.4% of patients achieved ...